🔎 Trials Near Me

Beranda › Kolitis Ulseratif › Texas › Tyler

Uji klinis Kolitis Ulseratif di Tyler, TX

14 studi untuk Kolitis Ulseratif mencari peserta di lokasi sekitar Tyler (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 2
  • Tyler Research Institute, Tyler
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • Xencor Investigative Site, Tyler
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06619990

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 2
  • Site US-004, Tyler
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 3
  • Tyler Research Institute, LLC, Tyler
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Menerima pesertaFase 3
  • Tyler Research Institute, Tyler
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Menerima pesertaFase 2
  • Tyler Research Institute, Tyler
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 2
  • Tyler Research Institute, Tyler
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Menerima pesertaFase 4
  • Tyler Research Institute, LLC, Tyler
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 3
  • Tyler Research Institute, LLC - Site Number: 8400095, Tyler
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07185009

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Menerima pesertaFase 3
  • Tyler Research Institute ( Site 0294), Tyler
Semua usia · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06651281

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 3
  • Tyler Research Institute, LLC, Tyler
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Menerima pesertaFase 3
  • Tyler Research Institute, LLC - Site Number: 8400095, Tyler
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07184996

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Menerima pesertaFase 2
  • Tyler Research Institute, LLC, Tyler
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06764615

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Menerima pesertaFase 2
  • Mirador Therapeutics Selected Site, Tyler
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522

Uji klinis Kolitis Ulseratif di kota lain

Studi lain di Tyler

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.